Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (22)

2023

  1. A Pilot Study: The Reduction in Fecal Acetate in Obese Patients after Probiotic Administration and Percutaneous Electrical Neurostimulation

    Nutrients, Vol. 15, Núm. 5

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Zinc levels of patients with a moderate to severe COVID-19 infection at hospital admission and after 4th days of ward hospitalization and their clinical outcome

    Journal of Trace Elements in Medicine and Biology, Vol. 79

2022

  1. CCN2 (Cellular Communication Network Factor 2) Deletion Alters Vascular Integrity and Function Predisposing to Aneurysm Formation

    Hypertension, Vol. 79, Núm. 3, pp. E42-E55

  2. Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm

    Science Advances, Vol. 8, Núm. 11

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Mcp-1 predicts recurrent cardiovascular events in patients with persistent inflammation

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-13

2020

  1. Addition of probiotics to anti-obesity therapy by percutaneous electrical stimulation of dermatome T6. A pilot study

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 19, pp. 1-14

  2. CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice

    FASEB Journal, Vol. 34, Núm. 11, pp. 14960-14976

2018

  1. Bisphenol A is an exogenous toxin that promotes mitochondrial injury and death in tubular cells

    Environmental Toxicology, Vol. 33, Núm. 3, pp. 325-332

  2. Branched-chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation

    Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 10, pp. 4948-4962

  3. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease

    Atherosclerosis, Vol. 270, pp. 13-20

  4. Influence of dialysis membrane composition on plasma bisphenol A levels during online hemodiafiltration

    PLoS ONE, Vol. 13, Núm. 3

  5. Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: Role of GLP-1 isoforms in Glut4 receptor trafficking

    Cardiovascular Diabetology, Vol. 17, Núm. 1

2017

  1. Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 10, pp. 207-222

  2. Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease

    Atherosclerosis, Vol. 260, pp. 130-137

  3. TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice

    Scientific Reports, Vol. 7

2015

  1. Targeting metabolic disturbance in the diabetic heart

    Cardiovascular Diabetology, Vol. 14, Núm. 1

  2. Updating experimental models of diabetic cardiomyopathy

    Journal of Diabetes Research, Vol. 2015

2014

  1. Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis

    Journal of the American Heart Association, Vol. 3, Núm. 4